Table of Contents
Chapter 1.Executive Summary
1.1.Market Snapshot
1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1.Antipsychotic Drugs Market, by region, 2020-2030 (USD Billion)
1.2.2.Antipsychotic Drugs Market, by Disease, 2020-2030 (USD Billion)
1.2.3.Antipsychotic Drugs Market, by Drug, 2020-2030 (USD Billion)
1.2.4.Antipsychotic Drugs Market, by Therapeutic Class, 2020-2030 (USD Billion)
1.2.5.Antipsychotic Drugs Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3.Key Trends
1.4.Estimation Methodology
1.5.Research Assumption
Chapter 2.Global Antipsychotic Drugs Market Definition and Scope
2.1.Objective of the Study
2.2.Market Definition & Scope
2.2.1.Industry Evolution
2.2.2.Scope of the Study
2.3.Years Considered for the Study
2.4.Currency Conversion Rates
Chapter 3.Global Antipsychotic Drugs Market Dynamics
3.1.Antipsychotic Drugs Market Impact Analysis (2020-2030)
3.1.1.Market Drivers
3.1.1.1.Increasing number of awareness programs focusing on mental health
3.1.1.2.Rising prevalence of mental health disorders
3.1.2.Market Challenges
3.1.2.1.Side effects associated with antipsychotic drugs
3.1.2.2.Rise in cost of mental health programs
3.1.3.Market Opportunities
3.1.3.1.Rise in the adoption of Long-Acting Injectables (LAIs)
3.1.3.2.Growing R&D initiatives for development of novel antipsychotic drugs
Chapter 4.Global Antipsychotic Drugs Market: Industry Analysis
4.1.Porter's 5 Force Model
4.1.1.Bargaining Power of Suppliers
4.1.2.Bargaining Power of Buyers
4.1.3.Threat of New Entrants
4.1.4.Threat of Substitutes
4.1.5.Competitive Rivalry
4.2.Porter's 5 Force Impact Analysis
4.3.PEST Analysis
4.3.1.Political
4.3.2.Economic
4.3.3.Social
4.3.4.Technological
4.3.5.Environmental
4.3.6.Legal
4.4.Top investment opportunity
4.5.Top winning strategies
4.6.COVID-19 Impact Analysis
4.7.Disruptive Trends
4.8.Industry Expert Perspective
4.9.Analyst Recommendation & Conclusion
Chapter 5.Global Antipsychotic Drugs Market, by Disease
5.1.Market Snapshot
5.2.Global Antipsychotic Drugs Market by Disease, Performance - Potential Analysis
5.3.Global Antipsychotic Drugs Market Estimates & Forecasts by Disease 2020-2030 (USD Billion)
5.4.Antipsychotic Drugs Market, Sub Segment Analysis
5.4.1.Schizophrenia
5.4.2.Bipolar Disorder
5.4.3.Unipolar Depression
5.4.4.Dementia
5.4.5.Others
Chapter 6.Global Antipsychotic Drugs Market, by Drug
6.1.Market Snapshot
6.2.Global Antipsychotic Drugs Market by Drug, Performance - Potential Analysis
6.3.Global Antipsychotic Drugs Market Estimates & Forecasts by Drug 2020-2030 (USD Billion)
6.4.Antipsychotic Drugs Market, Sub Segment Analysis
6.4.1.Risperidone
6.4.2.Quetiapine
6.4.3.Olanzapine
6.4.4.Aripiprazole
6.4.5.Brexpiprazole
6.4.6.Paliperidone Palmitate
6.4.7.Others
Chapter 7.Global Antipsychotic Drugs Market, by Therapeutic Class
7.1.Market Snapshot
7.2.Global Antipsychotic Drugs Market by Therapeutic Class, Performance - Potential Analysis
7.3.Global Antipsychotic Drugs Market Estimates & Forecasts by Therapeutic Class 2020-2030 (USD Billion)
7.4.Antipsychotic Drugs Market, Sub Segment Analysis
7.4.1.First Generation
7.4.2.Second Generation
7.4.3.Third Generation
Chapter 8.Antipsychotic Drugs Market, by Distribution Channel
8.1.Market Snapshot
8.2.Global Antipsychotic Drugs Market by Distribution Channel, Performance - Potential Analysis
8.3.Global Antipsychotic Drugs Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
8.4.Antipsychotic Drugs Market, Sub Segment Analysis
8.4.1.Hospital Pharmacies
8.4.2.Drug Stores & Retail Pharmacies
8.4.3.Online Pharmacies
Chapter 9.Global Antipsychotic Drugs Market, Regional Analysis
9.1.Top Leading Countries
9.2.Top Emerging Countries
9.3.Antipsychotic Drugs Market, Regional Market Snapshot
9.4.North America Antipsychotic Drugs Market
9.4.1.U.S. Antipsychotic Drugs Market
9.4.1.1.Disease breakdown estimates & forecasts, 2020-2030
9.4.1.2.Drug breakdown estimates & forecasts, 2020-2030
9.4.1.3.Therapeutic Class breakdown estimates & forecasts, 2020-2030
9.4.1.4.Distribution Channel breakdown estimates & forecasts, 2020-2030
9.4.2.Canada Antipsychotic Drugs Market
9.5.Europe Antipsychotic Drugs Market Snapshot
9.5.1.U.K. Antipsychotic Drugs Market
9.5.2.Germany Antipsychotic Drugs Market
9.5.3.France Antipsychotic Drugs Market
9.5.4.Spain Antipsychotic Drugs Market
9.5.5.Italy Antipsychotic Drugs Market
9.5.6.Rest of Europe Antipsychotic Drugs Market
9.6.Asia-Pacific Antipsychotic Drugs Market Snapshot
9.6.1.China Antipsychotic Drugs Market
9.6.2.India Antipsychotic Drugs Market
9.6.3.Japan Antipsychotic Drugs Market
9.6.4.Australia Antipsychotic Drugs Market
9.6.5.South Korea Antipsychotic Drugs Market
9.6.6.Rest of Asia Pacific Antipsychotic Drugs Market
9.7.Latin America Antipsychotic Drugs Market Snapshot
9.7.1.Brazil Antipsychotic Drugs Market
9.7.2.Mexico Antipsychotic Drugs Market
9.8.Middle East & Africa Antipsychotic Drugs Market
9.8.1.Saudi Arabia Antipsychotic Drugs Market
9.8.2.South Africa Antipsychotic Drugs Market
9.8.3.Rest of Middle East & Africa Antipsychotic Drugs Market
Chapter 10.Competitive Intelligence
10.1.Key Company SWOT Analysis
10.2.Top Market Strategies
10.3.Company Profiles
10.3.1.H. Lundbeck A/S (Denmark)
10.3.1.1.Key Information
10.3.1.2.Overview
10.3.1.3.Financial (Subject to Data Availability)
10.3.1.4.Product Summary
10.3.1.5.Recent Developments
10.3.2.Otsuka Pharmaceutical Co., Ltd. (Japan)
10.3.3.Janssen Pharmaceuticals, Inc. (Johnson & Johnson) (Belgium)
10.3.4.Eli Lilly and Company (U.S.)
10.3.5.ALLERGAN (AbbVie, Inc.) (U.S.)
10.3.6.Teva Pharmaceutical Industries Ltd. (Israel)
10.3.7.Dr. Reddy's Laboratories Ltd. (India)
10.3.8.Sumitomo Dainippon Pharma Co., Ltd. (Japan)
10.3.9.Alkermes plc (Ireland)
10.3.10.Bristol-Myers Squibb Company (U.S.)
Chapter 11.Research Process
11.1.Research Process
11.1.1.Data Mining
11.1.2.Analysis
11.1.3.Market Estimation
11.1.4.Validation
11.1.5.Publishing
11.2.Research Attributes
11.3.Research Assumption